Clinical Trials on Climacteric; Menorrhagia, Menopausal in Belgium

Total 20 results

Novo Nordisk A/S

Completed

Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations (CHOICE)

Menopause | Menopausal Vasomotor Symptoms

Denmark, United Kingdom, Sweden, Belgium, Switzerland, Germany, France, Finland, Austria, Norway
Serge Rozenberg
Jules Bordet Institute; Erasme University Hospital; NOVAVISION GROUP S.P.A; Centre... and other collaborators

Terminated

New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy (ViViA)

Genitourinary Syndrome of Menopause | Vulvo-vaginal Atrophy

Belgium
Brugmann University Hospital

Completed

Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation

Metrorrhagia

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors (LASI)

Genitourinary Syndrome of Menopause

Belgium
Novartis Pharmaceuticals

Completed

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Post-menopausal Osteoporosis

Colombia, Belgium, Sweden, Hong Kong, United States, Hungary, Switzerland, Australia, Germany, Italy, Canada, Poland, Argentina, Thailand, Norway, New Zealand, France, Finland
Hoffmann-La Roche

Completed

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Post Menopausal Osteoporosis

Spain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
University Hospital, Ghent

Recruiting

NovaSure Study: Endometrial Ablation in Women With Heavy Menstrual Bleeding (RAMBOS)

Menstrual Bleeding, Heavy

Belgium
Hoffmann-La Roche

Completed

MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis

Post Menopausal Osteoporosis

Australia, United Kingdom, United States, Brazil, Germany, South Africa, France, Spain, Switzerland, Italy, Canada, Hungary, Belgium, Mexico, Poland, Denmark, Norway, Czechia, Romania
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva

Post-Menopausal Osteoporosis

United States, Germany, United Kingdom, Spain, Italy, Hungary, Belgium, Mexico, Poland, Denmark, France, Norway, Brazil, Czechia
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Post-Menopausal Osteoporosis

Spain, South Africa, Germany, Mexico, Italy, Belgium, United States, Poland, Denmark, Hungary, Czech Republic, France, Norway, United Kingdom, Australia
Amgen

Completed

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

Post Menopausal Osteoporosis

Canada, Denmark, United States, Belgium, Poland, Spain, Australia
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaborators

Completed

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Breast Cancer | Infertility | Menopausal Symptoms

Italy, Australia, Switzerland, Belgium, Hungary, New Zealand
Bayer

Completed

Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).

Menopause

Belgium, Netherlands, Finland, United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause

Menopause

Belgium, Finland, Sweden, South Africa, Croatia, United Kingdom, France, Romania, Ukraine, Spain, Poland, Hungary, Czech Republic, Mexico, Netherlands
Bayer

Completed

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause (OASIS-3)

Hot Flashes | Vasomotor Symptoms Associated With Menopause

Belgium, United States, Poland, Spain, Bulgaria, Finland, Canada, Denmark, United Kingdom
GlaxoSmithKline

Terminated

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Osteoporosis

Germany, Russian Federation, Korea, Republic of, United States, Belgium, Hong Kong, Spain, Australia, Argentina, South Africa, Poland, Norway, Mexico, Denmark
Hoffmann-La Roche

Completed

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Belgium, Luxembourg, Austria, Greece, Ireland
Bayer

Recruiting

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause (NIRVANA)

Sleep Disturbances Associated With Menopause

United States, Germany, Belgium, Czechia, Poland, Austria, Spain, Netherlands
Myovant Sciences GmbH

Completed

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Uterine Fibroid | Heavy Menstrual Bleeding

United States, Belgium, Czechia, South Africa, Chile, Brazil, Hungary, Poland
Myovant Sciences GmbH

Completed

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Uterine Fibroid | Heavy Menstrual Bleeding

United States, Italy, Belgium, Czechia, Hungary, Poland, South Africa, Chile, Brazil

Clinical Trials on Climacteric; Menorrhagia, Menopausal in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations